Invicta Diagnostic Ipo
Invicta Diagnostic IPO Review & Key Points
Review: Neutral
Rating: 2
IPO Lead Managers aka Merchant Bankers
Socradamus Capital Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 3,200 | ₹2,72,000 |
| Retail Maximum | 2 | 3,200 | ₹2,72,000 |
| S-HNI Minimum | 3 | 4,800 | ₹4,08,000 |
| S-HNI Maximum | 7 | 11,200 | ₹9,52,000 |
| B-HNI Minimum | 8 | 12,800 | ₹10,88,000 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 7,98,400 Shares | 24.13% |
| QIB (Ex. Anchor) | 5,34,400 Shares | 16.15% |
| NII Shares Offered | 5,42,400 Shares | 16.39% |
| Retail Shares Offered | 12,67,200 Shares | 38.30% |
| Anchor Bidding Date | November 28, 2025 |
| Anchor Investors List | |
| Shares Offered | 7,98,400 Shares |
| Anchor Size | 6.79 Cr. |
| lock-in period end date 50% shares (30 Days) | January 4, 2025 |
| lock-in period end date 50% shares (90 Days) | March 3, 2025 |
| IPO Open Date: | December 1, 2025 |
| IPO Close Date: | December 3, 2025 |
| Basis of Allotment: | December 4, 2025 |
| Refunds: | December 5, 2025 |
| Credit to Demat Account: | December 5, 2025 |
| IPO Listing Date: | December 8, 2025 |
| IPO Bidding Cut-off Time: | December 3, 2025 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 92,63,173 | 91.89% |
| Promoter Holding Post Issue | 1,25,71,973 | -% |
| Purpose | Crores |
| Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra; and | ₹21.11 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2024 | ₹15.90 | ₹10.78 | ₹3.81 | ₹15.89 |
| 2025 | ₹30.18 | ₹23.62 | ₹4.93 | ₹21.22 |
| September 2025 | ₹17.08 | ₹11.65 | ₹4.08 | ₹34.90 |
| KPI | Values |
| ROE: | 44.28% |
| ROCE: | 42.00% |
| EBITDA Margin: | 30.57% |
| PAT Margin: | 16.38% |
| Debt to equity ratio: | 0.26 |
| Earning Per Share (EPS): | ₹5.86 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 36.25% |
| Net Asset Value (NAV): | ₹16.15 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Vijaya Diagnostic Centre Limited | 13.95 | 71.90 | 17.99% | 77.86 | – Cr. |
| Krsnaa Diagnostics Limited | 24.04 | 29.58 | 8.79% | 272.54 | – Cr. |
| IPO Open Date | December 1, 2025 |
| IPO Close Date | December 3, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹80 to ₹85 Per Share |
| Issue Size | Approx ₹28.12 Crores |
| Fresh Issue | Approx ₹28.12 Crores |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |